June 15, 2026 As the Ebola Epidemic Spreads, NV-387 Oral Gummies Can Enter a Phase II Clinical Trial for Treatment of Ebola – NanoViricides Proposal is Approved by the Pillar Committee in DR Congo
June 15, 2026 Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Demonstrating Improved Growth Measures in Pediatric Patients with Classic Congenital Adrenal Hyperplasia at ENDO 2026
June 15, 2026 World-first burn treatment with “absolutely remarkable” results performed at leading Canadian hospital
June 15, 2026 Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing
